BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 02/08/2013

Pfizer Withdraws FDA Approval of BEXTRA Tablets

The US Food and Drug Administration (FDA) is withdrawing approval of a new drug application for Pfizer's BEXTRA (valdecoxib) 10mg and 20mg tablets, following Pfizer's voluntary request to withdraw approval and waive a hearing.

Source: Federal Register — Food and Drug AdministrationOpen original release →